CMA Can Appeal Nixed £100M Fine In NHS Drug Pricing Case
The Competition and Markets Authority was granted permission on Monday to challenge a tribunal's ruling that overturned more than £100 million ($126 million) in fines against drug companies for fixing agreements...To view the full article, register now.
Already a subscriber? Click here to view full article